Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human

Ralf Arnold1, Brigitte König, Hermann Werchau

  • 1Institute of Medical Microbiology, Otto-von-Guericke-University, Magdeburg, Germany. ralf.arnold@medizin.uni-magdeburg.de

Virology
|November 30, 2004
PubMed

Insights

Respiratory syncytial virus (RSV) soluble G protein (sG) dampens lung epithelial cell inflammation, aiding viral replication. Deleting sG increases inflammatory markers and reduces RSV replication.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Respiratory syncytial virus (RSV) is a major infant respiratory pathogen.
  • The role of secreted G glycoprotein (sG) in RSV infection is not well understood.
  • RSV produces both membrane-anchored (mG) and secreted (sG) G proteins.

Purpose of the Study:

  • To investigate the biological role of RSV sG protein during infection.
  • To analyze the inflammatory response of lung epithelial cells infected with wild-type RSV (RSV-WT) versus an sG-deficient mutant (RSV-DeltasG).

Main Methods:

  • Infection of human lung epithelial cells (A549) with RSV-WT and RSV-DeltasG.
  • Analysis of ICAM-1 expression, chemokine (IL-8, RANTES) release, and transcription factor NF-kappaB activity.
  • Quantification of viral replication efficiency.

Main Results:

  • RSV-DeltasG induced higher ICAM-1 expression and increased IL-8 and RANTES release compared to RSV-WT.
  • Enhanced mRNA levels for ICAM-1, IL-8, and RANTES correlated with increased protein expression.
  • RSV-DeltasG showed increased NF-kappaB binding activity but less efficient replication than RSV-WT.

Conclusions:

  • RSV sG protein production appears to reduce detrimental inflammatory responses from infected lung epithelial cells.
  • This reduction in inflammation likely supports and enhances RSV replication during infection.
  • Understanding sG's role offers insights into RSV pathogenesis and potential therapeutic targets.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...